Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Director/PDMR Shareholding

25 Oct 2013 14:39

RNS Number : 4577R
TyraTech, Inc.
25 October 2013
 

25 October 2013

 

TYRATECH, INC.

("TyraTech" or the "Company")

 

Director/PDMR Shareholding

 

The Company has received notification that on 25 October 2013, Barry Riley, Non-Executive Director of the Company, completed the sale and repurchase, of a total of 273,334 common shares of US$0.001 in the Company ("Common Share") at a sale price of 5.5 pence per Common Share and a repurchase price of 5.52 pence per Common Share, in order to effect the transfer of 136,667 Common Shares to the Individual Savings Account ("ISA") of Barry Riley and 136,667 Common Shares to the ISA of Barry's wife, Mrs. B. Riley.

 

Following this transaction, Barry Riley remains beneficially interested in 2,455,556 Common Shares representing an interest of 1.46 per cent of the total voting rights of the Company. In addition, Barry Riley is interested in 550,000 stock appreciation right options over Common Shares as follows:

 

Options Held

Option Exercise Price

Expiry Date

200,000

12p

20 October 2020

350,000

6p

25 April 2022

 

 

 

For further information please contact:

 

TyraTech Inc.Alan Reade, Non-Executive ChairmanTel: +44 7841 978 709

 

Bruno Jactel, Chief Executive Officer

Tel: +1 919 415 4340

 

N+1 Singer, Nominated Adviser and Joint BrokerJonny Franklin-Adams / Alex WrightTel: +44 20 7496 3000

 

First Columbus LLP, Joint BrokerChris CrawfordTel: +44 20 3002 2070

 

Walbrook, Financial PR and IR

Bob Huxford /Guy McDougall (Public Relations)

Tel + 44 7933 8792

 

Paul Cornelius (Investor Relations)

Tel +44 20 7933 8794

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMABJTMBJTBFJ
Date   Source Headline
31st Jan 20144:26 pmRNSProposed Placing
23rd Jan 20145:58 pmRNSHolding(s) in Company
20th Jan 20147:00 amRNSHead-Lice Preventative Shampoo Coming to US Market
14th Jan 20147:00 amRNSChange of Adviser
14th Jan 20147:00 amRNSVamousse coming to Walmart stores in the USA
18th Dec 20137:00 amRNSBlocklisting Interim Review
25th Oct 20132:39 pmRNSDirector/PDMR Shareholding
7th Oct 20138:39 amRNSDirector/PDMR Shareholding
30th Sep 20137:00 amRNSInterim Results
14th Aug 20137:00 amRNSGlobal distribution agreement for biocide products
25th Jul 20136:11 pmRNSResult of AGM
27th Jun 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSDirectorate Changes
19th Jun 20139:59 amRNSBlocklisting Interim Review
11th Jun 20134:23 pmRNSDirectorate Change
31st May 201312:43 pmRNSMigration of Shares
11th Apr 20137:00 amRNSFrench Registration of Insect Repellent Product
9th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20136:09 pmRNSResult of Special Meeting
28th Mar 20134:15 pmRNSShare Migration
18th Mar 20137:00 amRNSProposed placing and subscription of common shares
4th Mar 20137:00 amRNSUK registration of insect repellent product
4th Feb 20137:00 amRNSFirst Patent Granted for ExtendT Technology
10th Jan 20137:00 amRNSDirectorate Change
7th Jan 201310:40 amRNSNew Anti-Endoparasitic Composition Patents
20th Dec 20127:00 amRNSIssue of Equity
18th Dec 20122:56 pmRNSBlocklisting Interim Review
18th Dec 20127:00 amRNSGerman Registration of Insect Repellent Product
17th Dec 20127:00 amRNSFirst Shipment of Retail Products
11th Dec 20127:00 amRNSHead Lice Product Registration in UK
4th Dec 20127:00 amRNSFormation of New Joint Venture
13th Nov 20127:00 amRNSU.S. Registration of New Insect Repellent Product
30th Oct 20127:00 amRNSAdvance Payment on Prospective New Alliance
29th Oct 20127:00 amRNSChange of Name of Adviser
16th Oct 201211:40 amRNSTyraTech Secures New Patent
16th Oct 20129:26 amRNSMigration of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.